Saint Helena vs Vanuatu: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Saint Helena
2.0%
in 2024
Vanuatu
1.8%
in 2024
Saint Helena rank
12th
Vanuatu rank
14th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Saint Helena
- Vanuatu
How they compare
Saint Helena currently reports 2.0% against 1.8% in Vanuatu, a difference of 0.2%.
That makes Saint Helena's figure about 1.1 times Vanuatu's.
Across all 10 years both countries report, Saint Helena has been ahead every year.
Saint Helena ranks 12th and Vanuatu ranks 14th of 215 countries.
Saint Helena has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Helena | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 1.6% | 1.1% | Saint Helena |
| 2020s | 2.3% | 1.7% | 0.7% | Saint Helena |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Saint Helena or Vanuatu?
- Saint Helena, at 2.0% against 1.8% in Vanuatu as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Saint Helena and Vanuatu?
- 0.2%, with Saint Helena ahead.
- How many years of comparable data are there for Saint Helena and Vanuatu?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Helena and Vanuatu rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Saint Helena ranks 12th and Vanuatu ranks 14th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.